Amplius Wealth Advisors’s Hologic HOLX Stock Holding History

Amplius Wealth Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-38	Closed	-$2K	–	484
2021 Q4	$2K	Buy	+38	New	+$2.79K	﹤0.01%	837

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Amplius Wealth Advisors's HOLX Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Hologic (HOLX) in Q1 2022, closing a stake of 38 shares — an estimated $2K sold.

Amplius Wealth Advisors first reported a position in HOLX in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 700 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

Amplius Wealth Advisors reported no remaining Hologic position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 38 Hologic shares in Q1 2022, an estimated $2K.
Amplius Wealth Advisors first reported a position in Hologic in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's Hologic position peaked at $2K in Q4 2021.
700 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.